Drug Interactions between lapatinib and Microgestin Fe 1/20
This report displays the potential drug interactions for the following 2 drugs:
- lapatinib
- Microgestin Fe 1/20 (ethinyl estradiol/norethindrone)
Interactions between your drugs
ethinyl estradiol lapatinib
Applies to: Microgestin Fe 1 / 20 (ethinyl estradiol / norethindrone) and lapatinib
Lapatinib may increase the blood levels and effects of ethinyl estradiol. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Contact your doctor if you experience increased side effects or your condition changes. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
norethindrone lapatinib
Applies to: Microgestin Fe 1 / 20 (ethinyl estradiol / norethindrone) and lapatinib
Lapatinib may increase the blood levels and effects of norethindrone. You may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. Contact your doctor if you experience increased side effects or your condition changes. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
norethindrone food
Applies to: Microgestin Fe 1 / 20 (ethinyl estradiol / norethindrone)
Grapefruit juice may increase the blood levels of certain medications such as norethindrone. You may want to limit your consumption of grapefruit and grapefruit juice during treatment with norethindrone. However, if you have been regularly consuming grapefruit or grapefruit juice with the medication, then it is advisable for you to talk with your doctor before changing the amounts of these products in your diet, as this may alter the effects of your medication. Contact your doctor if your condition changes or you experience increased side effects. Orange juice is not expected to interact.
lapatinib food
Applies to: lapatinib
Take lapatinib on an empty stomach 1 hour before or 1 hour after a meal unless otherwise directed by your doctor. This will make it easier for your body to absorb the medication. The lapatinib dose is administered once daily and should not be divided. The usual dose of lapatinib is equal to 5 tablets. You may swallow each tablet one at a time, but take the entire lapatinib dose at the same time each day. If you are receiving therapy with lapatinib you should be advised to avoid grapefruits and grapefruit juice. Grapefruit can raise the levels of lapatinib in your body and lead to dangerous side effects.
ethinyl estradiol food
Applies to: Microgestin Fe 1 / 20 (ethinyl estradiol / norethindrone)
Consumer information for this interaction is not currently available.
MONITOR: Coadministration of ethinyl estradiol may increase the plasma concentrations of drugs that are primarily metabolized by CYP450 1A2. In a study of 30 healthy volunteers administered the CYP450 1A2 substrate tizanidine, the systemic exposure (AUC) of tizanidine was 3.9 times greater in women using an oral contraceptive containing ethinyl estradiol.
MANAGEMENT: Patients should be monitored for increased adverse effects of the CYP450 1A2 substrate during concomitant use with ethinyl estradiol. Product labeling for the specific CYP450 1A2 substrate should be consulted for additional recommendations.
ethinyl estradiol food
Applies to: Microgestin Fe 1 / 20 (ethinyl estradiol / norethindrone)
Information for this minor interaction is available on the professional version.
ethinyl estradiol food
Applies to: Microgestin Fe 1 / 20 (ethinyl estradiol / norethindrone)
Information for this minor interaction is available on the professional version.
norethindrone food
Applies to: Microgestin Fe 1 / 20 (ethinyl estradiol / norethindrone)
Information for this minor interaction is available on the professional version.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.